|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/437 | (2006.01) |
| A61K 31/437 | (2013.01) | ||
| A61K 31/424 | (2006.01) | ||
| A61P 27/16 | (2018.01) | ||
| A61P 25/00 | (2006.01) | ||
| A61K 31/5513 | (2013.01) |
| (11) | Patento numeris | 3576738 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 18747812.8 |
| Europos patento paraiškos padavimo data | 2018-02-02 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-12-11 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2022-10-12 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2018/016602 |
| Data | 2018-02-02 |
| (87) | Numeris | WO 2018/144827 |
| Data | 2018-08-09 |
| (30) | Numeris | Data | Šalis |
| 201762530528 P | 2017-07-10 | US | |
| 201762454280 P | 2017-02-03 | US | |
| 201762536669 P | 2017-07-25 | US |
| (72) |
DURING, Matthew , US
|
| (73) |
Ovid Therapeutics, Inc. ,
441 Ninth Avenue, New York, NY 10001,
US
|
| (54) | GABOXADOL MONOHYDRATE IN THE TREATMENT OF TINNITUS |
| GABOXADOL MONOHYDRATE IN THE TREATMENT OF TINNITUS |